Chas Pulido

Chas Pulido Email and Phone Number

General Partner @ Alix Ventures | Creator @ BIOS @ Alix Ventures
Chas Pulido's Location
San Francisco, California, United States, United States
Chas Pulido's Contact Details

Chas Pulido personal email

Chas Pulido phone numbers

About Chas Pulido

Chas Pulido is a 3rd generation healthcare executive, serial entrepreneur, & venture capitalist with a passion for helping startups drive patient impact.Chas founded Alix Ventures, where he serves as General Partner, to support high potential early stage Life Science startups engineering biology to drive radical advances in human health. He is particularly excited about startups at the intersection of technology & biology, known as “TechBio”, building platforms for “Novel Applications” (Therapeutics/Diagnostics) & “Bio-Economy Infrastructure” (Services/Manufacturing). Recognizing the TechBio movement at hand, Chas created BIOS - Content & community platform to unite Life Science industry innovators. To learn more about BIOS & initiatives check out: BIOS Medium (Top Writer - Venture Capital), BIOS Podcast (Top 5 Life Sciences), BIOS Daily Newsletter (25K+ Subscribers), BIOS Angels (World’s 1st TechBio Angel Investing Syndicate), & join our community - BIOS Commons (1000+ Members). Chas started his foray into venture capital with the opportunity to support Healthcare/Life Science (HC/LS) investments at Liquid 2 Ventures (L2V), led by Joe Montana - Hall of Fame Quarterback, a leading early stage VC fund focused on backing breakout founders - 750+ portfolio companies including standout HC/LS startups such as: Nurx, Truepill, Cerebral, Athelas, Solugen, H1 Insights, Cricket, Lively, Culture, Herophilus, Getlabs, 64x Bio, Xilis, amongst others. While @ L2V, Chas spent his time sourcing/diligencing new investments & helping portfolio founders excel in business development, hiring, & fundraising.Chas began his entrepreneurial pursuits at The University of Notre Dame where he majored in Management Consulting and served as an Innovation Fellow. His interests took him west to Silicon Valley through Y-Combinator with the founding of Pareto Life Sciences, the world’s first stem cell marketplace. In an effort to help patients access breakthrough treatments, he joined Clara Health (Acquired by M&B Sciences) - a leading clinical trial innovation startup - as an early employee to head business development & operations.  Outside of work, you can find Chas exploring his creativity while cooking, painting, glassblowing, or roaming about hiking, exploring museums, & traveling (70+ Countries/7 Continents).

Chas Pulido's Current Company Details
Alix Ventures

Alix Ventures

View
General Partner @ Alix Ventures | Creator @ BIOS
Chas Pulido Work Experience Details
  • Alix Ventures
    Founder & General Partner
    Alix Ventures 2020 - Present
    San Francisco, California, Us
    Alix Ventures: Driving Patient Impact - Supporting early stage Life Science startups engineering biology to drive radical advances in human healthBorn from our collective experience as founders, we set out to build the fund we wanted to raise from...Thesis: Life Sciences is experiencing rapid innovation with the rise of new generation of companies known as “TechBio” (Merging technology & biology), a change we believe is leading to some of the most impactful solutions in decades. Our passion is to help build transformative companies ahead of this revolution to significantly impact the quality & effectiveness of patient care. We aim to partner with passionate, accomplished founders who possess unique insights to solve some of the world’s most daring problems facing us in Life Sciences.Team: Our entire team is built of Life Science Founders with experience in raising capital, scaling teams, running labs, partnering with Pharma, & the many fires that consist of operating an early stage company.SAB: Composed of Bioengineering PhDs turned Founders, our Scientific Advisory Board provides deep technical expertise & fluency across a wide variety of Life Science sub-domains from platforms for “Novel Applications” (Therapeutics/Diagnostics) to “Bio-Economy Infrastructure” (Tools/Services/Manufacturing). Let’s talk science!Support: Helping our founders is our utmost priority. To tackle the many challenges ahead, we’ve curated a full platform of resources to help with customer introductions, fundraising, & team building, amongst others. In addition, dedicated to supporting our portfolio is our extensive network of industry executives spanning Top 25 Pharma, major health systems, & large Payors.Limited Partners: Anchored by leading strategic LPs making up some of the best venture capital firms in the world, veteran founders, & industry experts. Alix is here to fill the void for early stage Life Science capital.
  • Bios
    Creator
    Bios 2020 - Present
    Uniting the Life Science ecosystem in #PatientImpact — Spotlighting leaders in Academia, Startups, Pharma, & VC — By Alix Ventures
  • Mythic Therapeutics, Inc.
    Investor
    Mythic Therapeutics, Inc. 2021 - Present
    Waltham, Massachusetts, Us
    "Enhancing Therapeutic Potency Through Conditional Activation"Co-Investors: Viking Global, Foresite Capital, Perceptive Advisors, Venrock, First Round, OMX, Lifeforce, amongst others
  • Strand Therapeutics
    Investor
    Strand Therapeutics 2022 - Present
    Boston, Massachusetts, Us
    "Enabling Logic Gated Gene Therapy"Co-Investors: FPV, Playground, Redmile, Eli Lilly, amongst others
  • Elegen
    Investor
    Elegen 2020 - Present
    San Carlos, California, Us
    "Enabling Full Stack DNA Writing"Co-Investors: a16z, 8VC, KdT, amongst others
  • Chemify Limited
    Investor
    Chemify Limited 2023 - Present
    “Enabling Ultra-High Throughput Chemical Synthesis”Co-Investors: Stealth
  • Exthymic
    Investor
    Exthymic 2024 - Present
    “Stealth”
  • Galatea Bio Inc.
    Investor
    Galatea Bio Inc. 2022 - Present
    Miami Lakes, Florida, Us
    "Enabling Genomic Insights for Under Represented Populations"Co-Investors: F-Prime, Digitalis, AME Cloud, amongst others
  • Zafrens
    First Investor
    Zafrens 2021 - Present
    San Diego, California, Us
    "Enabling Ultra-High Throughput Single Cell Screening & Manipulation"Co-Investors: Stealth
  • Cytosolix, Inc.
    Investor
    Cytosolix, Inc. 2023 - Present
    "Enhancing Therapeutic Efficacy By Targeting Tumor Acidity"Co-Investors: Stealth
  • Clora
    Investor
    Clora 2021 - Present
    Boston, Massachusetts, Us
    "Empowering Premier Life Science Talent Placement"Co-Investors: Spark, Felicis, amongst others
  • Endpoint Health
    Investor
    Endpoint Health 2022 - Present
    Palo Alto, California, Us
    “Enabling Precision Immunology”Co-Investors: Mayfield Fund, AME Cloud Ventures, Boom Capital
  • Xilis
    Investor
    Xilis 2020 - Present
    Durham, North Carolina, Us
    “Enabling Precision Medicine Through Patient Derived Micro-Organoids”Co-Investors: Mubadala, GV, Felicis, 8VC, Two Sigma, FPV, amongst others
  • Strm.Bio
    Investor
    Strm.Bio 2023 - Present
    Boston, Ma, Us
    “Enabling Non-Viral Gene Therapy”Co-Investors: Stealth
  • 64X Bio
    Investor
    64X Bio 2021 - Present
    San Francisco, California, Us
    "Enabling Viral Vector Manufacturing"Co-Investors: Lifeforce Capital, Northpond Ventures, First Round, Future Ventures, amongst others
  • Basil Systems
    Investor
    Basil Systems 2021 - Present
    Boston, Ma, Us
    "Enabling Actionable Life Science Business Intelligence"Co-Investors: Golden Ventures, Looking Glass, Alumni Ventures, amongst others
  • Teiko.Bio
    Investor
    Teiko.Bio 2021 - Present
    Salt Lake City, Ut, Us
    “Enabling Next Generation Immune System Profiling”Co-Investors: HOF, GFC, Pathfinder (Founders Fund), Civilization Ventures, Tau Ventures, amongst others
  • Pair Team
    Investor
    Pair Team 2019 - Present
    San Francisco, Ca, Us
    “Enabling Care Coordination as a Service”Co-Investors: Kleiner Perkins, Craft Ventures, 8VC, NTT, amongst others
  • Getlabs
    First Investor & Advisor
    Getlabs 2019 - Present
    Remote, Us
    "Empowering the Future of Comprehensive At-Home Care"Co-Investors: Emerson Collective, Tusk, Pivot North, Liquid 2 Ventures, Lab Corp, amongst others
  • Circularis Biotechnologies
    Investor & Board Observer
    Circularis Biotechnologies 2020 - Oct 2022
    Oakland, Ca, Us
    “Enabling Gene Regulation & Promotion”Co-Investors: KdT, Cantos, SOSV, amongst others***Acquired by Gingko Bioworks***
  • Liquid 2 Ventures
    Entrepreneur In Residence
    Liquid 2 Ventures 2018 - 2019
    San Francisco, California, Us
    Liquid 2 Ventures, founded by NFL Hall of Fame quarterback Joe Montana and Y-Combinator backed founders Mike Miller (Cloudant YC s08) & Michael Ma (Talkbin YC w11), is a seed stage venture fund focused on backing great founders: 500+ investments.Early Investors: Rappi, Gitlab, Anduril, Rippling, Astranis, Mercury, Grin, & Lambda SchoolHealthcare/Biotech: Solugen, Cerebral, Nurx, Athelas, Truepill, 64x Bio, System 1 Biosciences, Lively, Cricket Health, Culture, H1 Insights, amongst others
  • Clara Health (Acquired By M&B Sciences)
    Interim Head Of Business Development & Operations
    Clara Health (Acquired By M&B Sciences) 2018 - 2018
    San Francisco, California, Us
    Clara Health is a clinical trial marketplace helping patients across access breakthrough treatments.Backed by: Founders Fund, Khosla, Longevity Fund, GFC, Abstract, amongst others
  • Pareto Life Sciences
    Co-Founder & Ceo
    Pareto Life Sciences 2017 - 2018
    San Francisco, California, Us
    Pareto is the world's first stem cell marketplace. We facilitate transplants, treatments, and research to save, enhance, and extend life.Y-Combinator S18
  • Crcl
    Founder & Ceo
    Crcl 2015 - 2017
    Usa, Us

Chas Pulido Skills

Entrepreneurship Team Leadership Social Media Marketing Public Speaking Business Development Microsoft Office Market Research Venture Capital Project Management Fundraising Pitching Ideas Product Launch Marketing Strategy Ui/ux Design Digital Marketing Design Thinking Business Model Development Intellectual Property Human Resources Research And Development Product Development Business Networking Contract Negotiation Business Advisory Team Recruiting Agile Application Development Go To Market Strategy Financial Modeling Healthcare Biotechnology Life Sciences Genomics Marketplace Beta Testing User Rentention Data Science Fp&a Tax Accounting Focus Groups Crowdfunding Logo Design Business To Business Online Marketplace

Chas Pulido Education Details

  • Y Combinator
    Y Combinator
  • University Of Notre Dame - Mendoza College Of Business
    University Of Notre Dame - Mendoza College Of Business
  • The Bishop'S School
    The Bishop'S School

Frequently Asked Questions about Chas Pulido

What company does Chas Pulido work for?

Chas Pulido works for Alix Ventures

What is Chas Pulido's role at the current company?

Chas Pulido's current role is General Partner @ Alix Ventures | Creator @ BIOS.

What is Chas Pulido's email address?

Chas Pulido's email address is ch****@****uid2.vc

What is Chas Pulido's direct phone number?

Chas Pulido's direct phone number is +185852*****

What schools did Chas Pulido attend?

Chas Pulido attended Y Combinator, University Of Notre Dame - Mendoza College Of Business, The Bishop's School.

What skills is Chas Pulido known for?

Chas Pulido has skills like Entrepreneurship, Team Leadership, Social Media Marketing, Public Speaking, Business Development, Microsoft Office, Market Research, Venture Capital, Project Management, Fundraising, Pitching Ideas, Product Launch.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.